AI Assistant
Blog
Pricing
Log In
Sign Up
P579 Risk of CMV reactivation in UC patients with previous history of CMV infection following infliximab or vedolizumab treatments
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
